1,282 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Flagship Harbor Advisors LLC
Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...
Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance
The outlook for Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International ...
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Fifth Third Bancorp
Fifth Third Bancorp cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by ...
Charles River price target lowered to $195 from $210 at BofA
BofA lowered the firm’s price target on Charles River (CRL) to $195 from $210 and keeps a Neutral rating on the shares. The firm updated its ...
Bank of America Securities Sticks to Its Hold Rating for Charles River Labs (CRL)
Bank of America Securities analyst Juan Avendano reiterated a Hold rating on Charles River Labs (CRL – Research Report) today and set a price ...
Abeona Therapeutics: Despite Some Competitive Pressure, This Looks Undervalued
Abeona Therapeutics Inc.'s promising gene therapy for RDEB, potential FDA approval, undervalued stock, and key risks. Click ...
Barchart on MSN6d
Charles River Laboratories' Quarterly Earnings Preview: What You Need to Know
Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. Valued at $8.6 billion by market ...